These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [ASS and dipyridamole combination. A decisive contribution to secondary prevention after stroke]. Haberl R MMW Fortschr Med; 2003 May; 145 Suppl 2():98. PubMed ID: 14579496 [No Abstract] [Full Text] [Related]
6. Antiplatelet treatment for secondary prevention of acute ischemic stroke and transient ischemic attacks: mechanisms, choices and possible emerging patterns of use. Moonis M; Fisher M Expert Rev Cardiovasc Ther; 2003 Nov; 1(4):611-5. PubMed ID: 15030260 [No Abstract] [Full Text] [Related]
7. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view. Gebel JM J Am Coll Cardiol; 2005 Sep; 46(5):752-5. PubMed ID: 16139120 [TBL] [Abstract][Full Text] [Related]
8. Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole. Weyrich AS; Skalabrin EJ; Kraiss LW Am J Ther; 2009; 16(2):164-70. PubMed ID: 19300042 [TBL] [Abstract][Full Text] [Related]
9. ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients? Rouhl RP; Lodder J Expert Rev Neurother; 2008 Nov; 8(11):1661-5. PubMed ID: 18986236 [TBL] [Abstract][Full Text] [Related]
10. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines. Hankey GJ Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741 [TBL] [Abstract][Full Text] [Related]
11. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy. Biller J J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153 [TBL] [Abstract][Full Text] [Related]
12. Aspirin and dipyridamole for the secondary prevention of stroke. Zielinski R; French L J Fam Pract; 1999 Feb; 48(2):92. PubMed ID: 10037534 [No Abstract] [Full Text] [Related]
13. Cardiac safety in the European Stroke Prevention Study 2 (ESPS2). Diener HC; Darius H; Bertrand-Hardy JM; Humphreys M; Int J Clin Pract; 2001 Apr; 55(3):162-3. PubMed ID: 11351768 [TBL] [Abstract][Full Text] [Related]
15. Use of dipyridamole in patients with recent stroke or TIA. Bernstein RA Am Fam Physician; 2005 Aug; 72(3):382, 384; author reply 384. PubMed ID: 16100852 [No Abstract] [Full Text] [Related]
16. Dipyridamole plus aspirin: the best regimen for stroke prevention after noncardioembolic focal cerebral ischemia. Jonas S; Grieco G Cerebrovasc Dis; 2006; 22(1):1-3. PubMed ID: 16567930 [No Abstract] [Full Text] [Related]
17. MATCH results: implications for the internist. Lutsep HL Am J Med; 2006 Jun; 119(6):526.e1-7. PubMed ID: 16750967 [TBL] [Abstract][Full Text] [Related]
18. [Clopidogrel protection is not increased further by ASS!]. Bogousslavsky J Praxis (Bern 1994); 2004 Aug; 93(35):1390. PubMed ID: 15468578 [No Abstract] [Full Text] [Related]
19. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected]. Kirshner HS Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660 [TBL] [Abstract][Full Text] [Related]
20. ["A.I.C.L.A." controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Part I: Protocol (author's transl)]. Bousser MG; Eschwege E; Haguenau M; Lefauconnier JM; Touboul D; Touboul PJ Rev Neurol (Paris); 1981; 137(5):333-41. PubMed ID: 7027408 [No Abstract] [Full Text] [Related] [Next] [New Search]